Atlas Trials

Boryung Biopharma Co., Ltd.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Boryung Biopharma Co., Ltd.

RecordFirmDate
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs (NCT05613127)Boryung Biopharma Co., Ltd.2022-12-01
To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years (NCT04618640)Boryung Biopharma Co., Ltd.2019-12-26
To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children (NCT04618939)Boryung Biopharma Co., Ltd.2016-10-20

Track Boryung Biopharma Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.